DAVID P SOUTHWELL Insider Trading
Get free email notifications about insider trading for DAVID P SOUTHWELL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DAVID P SOUTHWELL. DAVID P SOUTHWELL is a Director in HUMAN GENOME SCIENCES INC ($HGSI) and a Chief Financial Officer in Sunovion Pharmaceuticals Inc. ($SEPR) and an Executive VP and CEO in Sunovion Pharmaceuticals Inc. ($SEPR) and an Executive VP and CFO in Sunovion Pharmaceuticals Inc. ($SEPR) and a in ROCKET PHARMACEUTICALS, INC. ($RCKT) and a Director in ROCKET PHARMACEUTICALS, INC. ($RCKT) and a President and CEO in INOTEK PHARMACEUTICALS CORP ($ITEK) and a See Remarks in INOTEK PHARMACEUTICALS CORP ($ITEK) and a Director in PTC THERAPEUTICS, INC. ($PTCT) and a Director in Spero Therapeutics, Inc. ($SPRO).
Address: 350 MAIN ST CONCORD 01742 MA
Companies in which DAVID P SOUTHWELL is an Insider
HUMAN GENOME SCIENCES INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of DAVID P SOUTHWELL: Director
Holdings: 0 shares
Latest Transaction: Jul 24 2008
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
PTC THERAPEUTICS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID P SOUTHWELL: Director
Holdings: 3,300 shares
Current Value: $44,418
Latest Transaction: Jan 08 2021
$PTCT Market Capitalization: $452.34M
$PTCT Previous Close: $13.46
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ROCKET PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID P SOUTHWELL:
Holdings: 95,160 shares
Current Value: $161,772
Latest Transaction: Jun 16 2021
$RCKT Market Capitalization: $44.43M
$RCKT Previous Close: $1.70
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Spero Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID P SOUTHWELL: Director
Holdings: 0 shares
Latest Transaction: Jun 06 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Sunovion Pharmaceuticals Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID P SOUTHWELL: Chief Financial Officer, Executive VP and CEO, Executive VP and CFO
Holdings: 59,702 shares
Latest Transaction: May 17 2007
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of DAVID P SOUTHWELL
Sentiment: All, HGSI, PTCT, RCKT, SPRO, SEPR
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 16 2021 | RCKT | ROCKET PHARMACEUTI ... | SOUTHWELL DAVID P | Option Exercise | A | 47.25 | 12,236 | 578,151 | 12,236 | ||
| Jan 08 2021 | PTCT | PTC THERAPEUTICS, ... | SOUTHWELL DAVID P | Director | Option Exercise | A | 66.49 | 10,000 | 664,900 | 10,000 | |
| Jan 08 2021 | PTCT | PTC THERAPEUTICS, ... | SOUTHWELL DAVID P | Director | Grant | A | 0.00 | 1,650 | 0 | 3,300 | 1.7 K to 3.3 K (+100.00 %) |
| Oct 20 2020 | PTCT | PTC THERAPEUTICS, ... | SOUTHWELL DAVID P | Director | Option Exercise | M | 11.23 | 12,000 | 134,760 | 0 | |
| Oct 20 2020 | PTCT | PTC THERAPEUTICS, ... | SOUTHWELL DAVID P | Director | Option Exercise | M | 10.85 | 15,000 | 162,750 | 0 | |
| Oct 20 2020 | PTCT | PTC THERAPEUTICS, ... | SOUTHWELL DAVID P | Director | Sell | S | 52.18 | 500 | 26,089 | 1,650 | 2.2 K to 1.7 K (-23.26 %) |
| Oct 20 2020 | PTCT | PTC THERAPEUTICS, ... | SOUTHWELL DAVID P | Director | Sell | S | 51.52 | 11,500 | 592,434 | 2,150 | 13.7 K to 2.2 K (-84.25 %) |